What is the total amount raised from the new debt offering?

Axon Enterprise, Inc. raised a total of $1.75 billion from the private offering, comprising $1,000 million in 6.125% senior notes due 2030 and $750 million in 6.250% senior notes due 2033.

How does Axon plan to use the proceeds from this offering?

The company intends to use the net proceeds for general corporate purposes. This may include potentially repurchasing or redeeming its existing 0.50% Convertible Senior Notes due 2027, providing capital to support growth, and funding potential acquisitions or investments in new product lines, services, or technologies.

What are the key changes to Axon's credit facility?

The credit agreement was amended to increase the revolving credit facility by $100 million to a total of $300 million, with an additional $100 million expansion option. The maturity date was also extended from December 15, 2027, to March 11, 2030. Additionally, availability for letters of credit was increased by $20 million to $50 million.

Are there any significant restrictions or covenants associated with the new debt or credit facility?

Yes, the indentures for the new notes contain restrictions on liens, mergers, consolidations, and transfers of assets. They also include a provision requiring repurchase of notes upon a change of control event. The amended credit agreement includes affirmative and negative covenants, such as financial reporting, limitations on indebtedness and liens, and requires compliance with a maximum net leverage ratio of 3.50:1.00 and a minimum interest coverage ratio of 3.50:1.00.

AXON 8-K: Material Agreements

01—Abstract

Summary

Summary of the 8-K filed March 11, 2025. Cited figures are marked; the original filing is the authoritative source.

Axon Enterprise, Inc. (AXON) has announced the successful closing of its private offering of $1,000.0 million^a in 6.125% senior notes due 2030 and $750.0 million in 6.250% senior notes due 2033.

This $1.75 billion^b in aggregate principal amount of new debt, issued under separate indentures, is intended for general corporate purposes. Potential uses include repurchasing or redeeming existing convertible notes, funding growth initiatives, and supporting strategic acquisitions or investments in new technologies.

Concurrently, Axon amended its existing credit agreement, increasing its revolving credit facility by $100 million to $300 million^c (with an option for further increase) and extending the maturity date to March 11, 2030. These actions strengthen Axon's financial flexibility and capital structure, providing resources for continued expansion and strategic opportunities.

02—Key points

Key Highlights

Closed a $1.75 billion debt offering consisting of $1,000 million of 6.125% senior notes due 2030 and $750 million of 6.250% senior notes due 2033.
Net proceeds from the offering are earmarked for general corporate purposes, including potential repurchase of convertible notes, growth capital, and strategic acquisitions.
Amended credit agreement to increase the revolving credit facility by $100 million to $300 million, with a further $100 million expansion option.
Extended the maturity date of the credit agreement from December 15, 2027, to March 11, 2030.
The credit agreement amendments also increased letter of credit availability by $20 million to $50 million.
The new senior notes are not registered under the Securities Act and were offered to qualified institutional buyers and non-U.S. investors.
Indentures for the new notes include standard covenants related to liens, mergers, and change of control events.

03—Questions

Frequently Asked Questions

What is the total amount raised from the new debt offering?
Axon Enterprise, Inc. raised a total of $1.75 billion from the private offering, comprising $1,000 million in 6.125% senior notes due 2030 and $750 million in 6.250% senior notes due 2033.
How does Axon plan to use the proceeds from this offering?
The company intends to use the net proceeds for general corporate purposes. This may include potentially repurchasing or redeeming its existing 0.50% Convertible Senior Notes due 2027, providing capital to support growth, and funding potential acquisitions or investments in new product lines, services, or technologies.
What are the key changes to Axon's credit facility?
The credit agreement was amended to increase the revolving credit facility by $100 million to a total of $300 million, with an additional $100 million expansion option. The maturity date was also extended from December 15, 2027, to March 11, 2030. Additionally, availability for letters of credit was increased by $20 million to $50 million.
Are there any significant restrictions or covenants associated with the new debt or credit facility?
Yes, the indentures for the new notes contain restrictions on liens, mergers, consolidations, and transfers of assets. They also include a provision requiring repurchase of notes upon a change of control event. The amended credit agreement includes affirmative and negative covenants, such as financial reporting, limitations on indebtedness and liens, and requires compliance with a maximum net leverage ratio of 3.50:1.00 and a minimum interest coverage ratio of 3.50:1.00.

04—Continue

← View all 8-K filings